Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065156
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2003-07-17
Brief Title:
Lenalidomide SafetyEfficacy in Myelodysplastic Syndromes MDS Associated With a Deletion Del5q Cytogenetic Abnormality
Sponsor:
Celgene
Organization:
Celgene